Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126642302 | 12664230 | 2 | F | 20160818 | 20160818 | 20160825 | EXP | CN-ELI_LILLY_AND_COMPANY-CN201608006774 | ELI LILLY AND CO | 40.00 | YR | M | Y | 0.00000 | 20160825 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126642302 | 12664230 | 1 | PS | CIALIS | TADALAFIL | 1 | Oral | HALF OR THIRD OF 20MG TABLET ONCE OR TWICE A MONTH PRN | N | Y | 21368 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126642302 | 12664230 | 1 | Sexual dysfunction |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126642302 | 12664230 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126642302 | 12664230 | Erectile dysfunction | |
| 126642302 | 12664230 | Eye haemorrhage | Eye haemorrhage |
| 126642302 | 12664230 | Off label use | |
| 126642302 | 12664230 | Thrombosis | Thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126642302 | 12664230 | 1 | 2013 | 0 |